Modulation of NFAT-5, an outlying member of the NFAT family, in human keratinocytes and skin

American Journal of Translational Research

Volumn 1, Issue 2, 2009, Pages 184-202

  Al Daraji, Wael I ^a   Afolayan, John ^b   Zelger, Belger G ^c   Abdellaoui, Adel ^d   Zelger, Bernhard ^c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^c MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^d DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Cyclosporin A (CsA); Human keratinocytes; Hypertonicity; NFAT 5 (TonEBP); Psoriasis; UVR

Indexed keywords

CYCLOSPORIN A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; RAFFINOSE; STRESS ACTIVATED PROTEIN KINASE; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT 5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; EPIDERMIS CELL; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION PROFILING; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; NUCLEOTIDE SEQUENCE; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SKIN BIOPSY; SKIN CULTURE; TRANSCRIPTION REGULATION; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; WESTERN BLOTTING;

NUCLEA;

EID: 77953377168     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Rao A, Luo C and Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15: 707-747.
2. Lopez-Rodriguez C, Aramburu J, Rakeman AS and Rao A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc Natl Acad Sci U S A 1999; 96: 7214-7219.
3. Pan S, Tsuruta R, Masuda ES, Imamura R, Bazan F, Arai K, Arai N and Miyatake S. NFATz: a novel rel similarity domain containing protein. Biochem Biophys Res Commun 2000; 272: 765-776.
4. Ko BC, Turck CW, Lee KW, Yang Y and Chung SS. Purification, identification, and characterization of an osmotic response element binding protein. Biochem Biophys Res Commun 2000; 270: 52-61.
5. Trama J, Lu Q, Hawley RG and Ho SN. The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner. J Immunol 2000; 165: 4884-4894.
6. Miyakawa H, Woo SK, Dahl SC, Handler JS and Kwon HM. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc Natl Acad Sci U S A 1999; 96: 2538-2542.
7. Lopez-Rodriguez C, Aramburu J, Jin L, Rakeman AS, Michino M and Rao A. Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 2001; 15: 47-58.
8. Yancey PH, Clark ME, Hand SC, Bowlus RD and Somero GN. Living with water stress: evolution of osmolyte systems. Science 1982; 217: 1214-1222.
9. Kwon ED, Zablocki K, Jung KY, Peters EM, Garcia-Perez A and Burg MB. Osmoregulation of GPC:choline phosphodiesterase in MDCK cells: different effects of urea and NaCl. Am J Physiol 1995; 269: C35-41.
10. Kwon ED, Jung KY, Edsall LC, Kim HY, Garcia-Perez A and Burg MB. Osmotic regulation of synthesis of glycerophosphocholine from phosphatidylcholine in MDCK cells. Am J Physiol 1995; 268: C402-412.
11. Burg MB, Kwon ED and Kultz D. Osmotic regulation of gene expression. Faseb J 1996; 10: 1598-1606.
12. Zablocki K, Miller SP, Garcia-Perez A and Burg MB. Corrections and retraction: accumulation of glycerophosphocholine (gpc) by renal cells: osmotic regulation of gpc:choline phosphodiesterase. Proc Natl Acad Sci U S A 1991; 88: 9907.
13. Zablocki K, Miller SP, Garcia-Perez A and Burg MB. Accumulation of glycerophosphocholine (GPC) by renal cells: osmotic regulation of GPC:choline phosphodiesterase. Proc Natl Acad Sci U S A 1991; 88: 7820-7824.
14. Garcia-Perez A and Burg MB. Renal medullary organic osmolytes. Physiol Rev 1991; 71: 1081-1115.
15. Miyakawa H, Rim JS, Handler JS and Kwon HM. Identification of the second tonicity-responsive enhancer for the betaine transporter (BGT1) gene. Biochim Biophys Acta 1999; 1446: 359-364.
16. Lopez-Rodriguez C, Aramburu J, Rakeman AS, Copeland NG, Gilbert DJ, Thomas S, Disteche C, Jenkins NA and Rao A. NF-AT5: the NF-AT family of transcription factors expands in a new direction. Cold Spring Harb Symp Quant Biol 1999; 64: 517-526.
17. Graef IA, Gastier JM, Francke U and Crabtree GR. Evolutionary relationships among Rel domains indicate functional diversification by recombination. Proc Natl Acad Sci U S A 2001; 98: 5740-5745.
18. Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O. Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 1998; 5: 355-364.
19. Hebinck A, Dalski A, Engel H, Mattei M, Hawken R, Schwinger E and Zuhlke C. Assignment of transcription factor NFAT5 to human chromosome 16q22.1, murine chromosome 8D and porcine chromosome 6p1.4 and comparison of the polyglutamine domains. Cytogenet Cell Genet 2000; 90: 68-70.
20. Kim JH, Hong JA, Pih KT and Hwang I. Identification and isolation of differentially expressed genes in osmotically stressed human oral keratinocytes. Arch Oral Biol 2001; 46: 335-341.
21. Garmyn M, Mammone T, Pupe A, Gan D, Declercq L and Maes D. Human Keratinocytes Respond to Osmotic Stress by p38 Map Kinase Regulated Induction of HSP70 and HSP27. J Invest Dermatol 2001; 117: 1290-1295.
22. Zhang QS, Maddock DA, Chen JP, Heo S, Chiu C, Lai D, Souza K, Mehta S and Wan YS. Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes. Int J Oncol 2001; 19: 1057-1061.
23. Hibi M, Lin A, Smeal T, Minden A and Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993; 7: 2135-2148.
24. Jain J, Valge-Archer VE, Sinskey AJ and Rao A. The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter. J Exp Med 1992; 175: 853-862.
25. Dmitrieva N, Kultz D, Michea L, Ferraris J and Burg M. Protection of renal inner medullary epithelial cells from apoptosis by hypertonic stress-induced p53 activation. J Biol Chem 2000; 275: 18243-18247.
26. Su B, Jacinto E, Hibi M, Kallunki T, Karin M and Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994; 77: 727-736.
27. Werlen G, Jacinto E, Xia Y and Karin M. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. Embo J 1998; 17: 3101-3111.
28. Matsuda S, Moriguchi T, Koyasu S and Nishida E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J Biol Chem 1998; 273: 12378-12382.
29. Matsuda S, Shibasaki F, Takehana K, Mori H, Nishida E and Koyasu S. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep 2000; 1: 428-434.
30. Matsuda S and Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology 2000; 47: 119-125.
31. Metcalfe S, Alexander D and Turner J. FK 506 and cyclosporin each block antigen-induced T cell receptor signaling that is dependent on CD4 co-receptor and operates in the absence of detectable cytoplasmic calcium fluxes. Transpl Int 1994; 7: S549-551.
32. Metcalfe S, Alexander D and Turner J. FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. Cell Immunol 1994; 158: 46-58.
33. Freshney RI. Culture of animal cells: a manual of basic techniques. New York: John Wiley and Sons Inc,, 2000.
34. Sharpe GR, Fisher C, Gillespie JI and Greenwell JR. Growth and differentiation stimuli induce different and distinct increases in intracellular free calcium in human keratinocytes. Arch Dermatol Res 1993; 284: 445-450.
35. Todd C and Reynolds NJ. Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway. Am J Pathol 1998; 153: 39-45.
36. Boyce ST and Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 1983; 81: 33s-40s.
37. Wille JJ, Jr., Pittelkow MR, Shipley GD and Scott RE. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyzes, growth kinetics, and cell cycle studies. J Cell Physiol 1984; 121: 31-44.
38. Pittelkow MR and Scott RE. New techniques for the in vitro culture of human skin keratinocytes and perspectives on their use for grafting of patients with extensive burns. Mayo Clin Proc 1986; 61: 771-777.
39. Al-Daraji WI, Grant KR, Ryan K, Saxton A and Reynolds NJ. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J Invest Dermatol 2002; 118: 779-788.
40. Al-Daraji WI and Reynolds NJ. Nifedipine inhibits nuclear translocation of NFAT1 in human keratinocytes. Clin Exp Dermatol 2005; In press:
41. Melan MA and Sluder G. Redistribution and differential extraction of soluble proteins in permeabilized cultured cells. Implications for immunofluorescence microscopy. J Cell Sci 1992; 101: 731-743.
42. Harlow E and Lane D. Using antibodies: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1999.
43. Zhou FC, Lumeng L and Li TK. Quantitative immunocytochemical evaluation of serotonergic innervation in alcoholic rat brain. Neurochem Int 1995; 26: 135-143.
44. Vente JD, Garssen J, Tilders FJ, Steinbusch HW and Schipper J. Single cell quantitative immunocytochemistry of cyclic GMP in the superior cervical ganglion of the rat. Brain Res 1987; 411: 120-128.
45. Sambrook J and Russel D. Molecular cloning: a laboratory maual. New York: Cold Spring Harbor Laboratory Press, 2000.
46. Farr PM and Diffey BL. The erythemal response of human skin to ultraviolet radiation. Br J Dermatol 1985; 113: 65-76.
47. Dahl SC, Handler JS and Kwon HM. Hypertonicity-induced phosphorylation and nuclear localization of the transcription factor TonEBP. Am J Physiol Cell Physiol 2001; 280: C248-253.
48. Denda M, Sato J, Masuda Y, Tsuchiya T, Koyama J, Kuramoto M, Elias PM and Feingold KR. Exposure to a dry environment enhances epidermal permeability barrier function. J Invest Dermatol 1998; 111: 858-863.
49. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM and Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 2001; 98: 13681-13686.
50. Gomez del Arco P, Martinez-Martinez S, Maldonado JL, Ortega-Perez I and Redondo JM. A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp. J Biol Chem 2000; 275: 13872-13878.
51. Porter CM, Havens MA and Clipstone NA. Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization. J Biol Chem 2000; 275: 3543-3551.
52. Chow CW, Rincon M, Cavanagh J, Dickens M and Davis RJ. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 1997; 278: 1638-1641.
53. Zhu J, Shibasaki F, Price R, Guillemot JC, Yano T, Dotsch V, Wagner G, Ferrara P and McKeon F. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell 1998; 93: 851-861.
54. Okamura H, Aramburu J, Garcia-Rodriguez C, Viola JP, Raghavan A, Tahiliani M, Zhang X, Qin J, Hogan PG and Rao A. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell 2000; 6: 539-550.
55. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ and Flavell RA. Defective T cell differentiation in the absence of Jnk1. Science 1998; 282: 2092-2095.
56. Dolmetsch RE, Lewis RS, Goodnow CC and Healy JI. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 1997; 386: 855-858.
57. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, Jablonska S, Ahmed I, Thestrup-Pedersen K, Daniel F, Finzi A and Reitamo S. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 337: 816-821.
58. Remitz A, Reitamo S, Erkko P, Granlund H and Lauerma AI. Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol 1999; 141: 103-107.
59. Shore RN. Clearing of psoriatic lesions after the application of tape. N Engl J Med 1985; 312: 246.
60. Shore RN. Treatment of psoriasis with prolonged application of tape. J Am Acad Dermatol 1986; 15: 540-542.
61. Friedman SJ. Management of psoriasis vulgaris with a hydrocolloid occlusive dressing. Arch Dermatol 1987; 123: 1046-1052.
62. Griffiths CE, Tranfaglia MG and Kang S. Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study. J Am Acad Dermatol 1995; 32: 618-622.
63. Gormar FE, Bernd A, Bereiter-Hahn J and Holzmann H. A new model of epidermal differentiation: induction by mechanical stimulation. Arch Dermatol Res 1990; 282: 22-32.
64. Bauerfeind R, Takei K and De Camilli P. Amphiphysin I is associated with coated endocytic intermediates and undergoes stimulation-dependent dephosphorylation in nerve terminals. J Biol Chem 1997; 272: 30984-30992.
65. Dascalu A, Nevo Z and Korenstein R. The control of intracellular pH in cultured avian chondrocytes. J Physiol 1993; 461: 583-599.
66. Parsegian VA, Rand RP and Rau DC. Osmotic stress, crowding, preferential hydration, and binding: A comparison of perspectives. Proc Natl Acad Sci U S A 2000; 97: 3987-3992.
67. Dascalu A, Matithyou A, Oron Y and Korenstein R. A hyperosmotic stimulus elevates intracellular calcium and inhibits proliferation of a human keratinocyte cell line. J Invest Dermatol 2000; 115: 714-718.
68. Franchi-Gazzola R, Visigalli R, Dall'Asta V, Sala R, Woo SK, Kwon HM, Gazzola GC and Bussolati O. Amino acid depletion activates TonEBP and sodium-coupled inositol transport. Am J Physiol Cell Physiol 2001; 280: C1465-1474.
69. Morris RJ, Fischer SM and Slaga TJ. Evidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen. Cancer Res 1986; 46: 3061-3066.
70. Morris RJ, Coulter K, Tryson K and Steinberg SR. Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling. Cancer Res 1997; 57: 3436-3443.
71. Huang C, Mattjus P, Ma WY, Rincon M, Chen NY, Brown RE and Dong Z. Involvement of nuclear factor of activated T cells activation in UV response. Evidence from cell culture and transgenic mice. J Biol Chem 2000; 275: 9143-9149.
72. Reynolds NJ and Al-Daraji WI. Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology. Clin Exp Dermatol 2002; 27: 555-561.